Intrexon Raises $25M in Equity Financing | GenomeWeb

NEW YORK (GenomeWeb News) – Genetic engineering company Intrexon has raised $25 million in equity financing, according to a form filed this week with the SEC.

Intrexon, formerly known as Genomatix, is based in Blacksburg, Va., and uses modular DNA control systems to enhance capabilities, improve safety, and lower cost in human therapeutics, protein production, industrial enzymes, and agriculture, according to the company's website.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: Plasmodium knowlesi population structure, 'pre-adaptations' in algal ancestors of land plants, and more.

Replication studies that don't quite reflect the original findings underscore the need to better share data, the Wall Street Journal reports.

About two-thirds of proposals to work with select agents are denied — though most proposals that come in don't meet the definition of a restricted experiment, according to an analysis by the Centers for Disease Control and Prevention.

Researchers examine plant and human DNA found on the Shroud of Turin.